Area of research
Cardiology and Cardiovascular Medicine · Physiology
Research interest
Research interests include Nitric Oxide and Endothelin Effects, Cardiac Imaging and Diagnostics, Takotsubo Cardiomyopathy and Associated Phenomena, and Cardiovascular Function and Risk Factors.
Thrombospondin-1 Drives Cardiac Remodeling in Chronic Kidney Disease
Impact of Atrial Fibrillation on Outcome in Takotsubo Syndrome: Data From the International Takotsubo Registry
Ethnic comparison in takotsubo syndrome: novel insights from the International Takotsubo Registry
Coexistence and outcome of coronary artery disease in Takotsubo syndrome
Age-Related Variations in Takotsubo Syndrome
Outcomes Associated With Cardiogenic Shock in Takotsubo Syndrome
Cardiac arrest in takotsubo syndrome: results from the InterTAK Registry
Clinical Features and Outcomes of Patients With Malignancy and Takotsubo Syndrome: Observations From the International Takotsubo Registry
Intraventricular Thrombus Formation and Embolism in Takotsubo Syndrome
Impact of Aspirin on Takotsubo Syndrome: A Propensity Score-Based Analysis of the InterTAK Registry
Clinical Predictors and Prognostic Impact of Recovery of Wall Motion Abnormalities in Takotsubo Syndrome: Results From the International Takotsubo Registry
Prediction of Short- and Long-Term Mortality in Takotsubo Syndrome: The InterTAK Prognostic Score
International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology
International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management
Long-Term Prognosis of Patients With Takotsubo Syndrome
Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial
Asymmetric and Symmetric Dimethylarginine Predict Outcomes in Patients With Atrial Fibrillation
Long-Term Effect of Endothelin Receptor Antagonism With Bosentan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure
Biomarkers of inflammation and risk of cardiovascular events in anticoagulated patients with atrial fibrillation
Interplay between Oxidative Stress and Inflammation in Cardiometabolic Syndrome
Growth Differentiation Factor 15, a Marker of Oxidative Stress and Inflammation, for Risk Assessment in Patients With Atrial Fibrillation
D‐dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation – observations from the ARISTOTLE trial
N-Terminal Pro–B-Type Natriuretic Peptide for Risk Assessment in Patients With Atrial Fibrillation
High-Sensitivity Troponin T and Risk Stratification in Patients With Atrial Fibrillation During Treatment With Apixaban or Warfarin
No Association of G-Protein-Coupled Receptor Kinase 5 or β-Adrenergic Receptor Polymorphisms with Takotsubo Cardiomyopathy in a Large Australian Cohort
Enhanced NO Signaling in Patients with Takotsubo Cardiomyopathy: Short-Term Pain, Long-Term Gain?
Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial